Enochian Biosciences Inc.

10/12/2021 | Press release | Distributed by Public on 10/12/2021 16:59

Fireside Chat with Enochian BioSciences’ CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

Enochian BioSciences

Enochian BioSciences is a biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. Our gene-modified cell therapy platform can be applied to multiple indications including HIV/AIDS and Oncology.

© 2019EnochianBio. All rights reserved. Powered by getfused